25338 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

narcolepsy reduce the risk for motor 

vehicle crashes; and the impact of 

various medication therapies for 

narcolepsy on driver safety. 

The evidence report reviewed studies 

from the available literature and 

evaluated outcomes on measures of 

Excessive Daytime Sleepiness (EDS), 

cataplexy, event rate, measures of 

cognitive and psychomotor function, 

and driving performance. The currently 

available direct and indirect evidence 

supports the contention that drivers 

with narcolepsy are at an increased risk 

for a motor vehicle crash when 

compared to otherwise similar 

individuals who do not have the 

disorder. The direct evidence from three 

crash studies conducted of non-CMV 

drivers showed that individuals with 

narcolepsy are at an increased risk for 

a crash compared to individuals who do 

not have narcolepsy. The indirect 

evidence from studies of driving tests 

and driving simulation examined factors 

associated with simulated driving 

outcomes such as driving performance, 

tracking error, fewer correct responses, 

and more instances of going out of 

bounds compared to healthy controls. 

While there are limitations in the 

quality of the studies that examined 

direct crash risk, both the direct and 

indirect studies showed a strong effect 

size and statistical significance. The 

American Academy of Sleep Medicine 

(AASM) and the European Federation of 

Neurological Societies recommend 

modafinil as the first treatment option 

and methylphenidate as the second 

treatment option. The AASM also 

recommends amphetamine, 

methamphetamine, or 

dextroamphetamine as alternative 

treatments. During literature searches, 

no studies that directly examined the 

impact of treatment with modafinil, 

armodafinil, sodium oxybate (used with 

narcolepsy with cataplexy), or antidepressants on crash risk or driving 

performance were identified. Therefore, 

conclusions regarding treatment with 

these medications on crash risk and 

driving performance could not be made. 

Currently available evidence suggests 

that amphetamines and/or 

methylphenidate are effective in 

improving symptoms of EDS in 

individuals with narcolepsy (quality of 

studies range from ‘‘moderate to low’’). 

However, these improvements do not 

result in levels of daytime sleepiness 

that can be considered to be normal in 

the vast majority of individuals. 

Therefore, conclusions regarding to the 

impact of treatment with amphetamines, 

methylphenidate, or other related 

stimulant drugs on cognitive and 

psychomotor function among 

individuals with narcolepsy could not 

be made. 

In January 2010, the FMCSA’s MRB 

recommended that individuals with 

narcolepsy be ineligible for a 

commercial driver’s license, even with 

treatment. 

Discussion of Comments 

FMCSA received one comment in this 

proceeding from a private citizen who 

did not support granting an exemption 

in the interest of public safety and the 

applicant’s well-being. The commenter 

cites that the applicant’s medical 

provider states that the applicant’s 

current treatment has proven effective 

and that treatment continues without 

explicit determination by the medical 

provider that the current regimen has 

sufficiently remedied the applicant’s 

medical condition such that it would 

not interfere with the ability to drive a 

CMV in the future. FMCSA 

acknowledges the commenter’s concern. 

When evaluating a medical exemption 

application request, FMCSA considers 

the applicant’s relevant medical 

information, however the Agency does 

not make a decision to grant or deny a 

medical exemption solely on the basis 

of an applicant’s medical 

documentation. 

III. Basis for Exemption Determination 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 

greater than, the level that would be 

achieved absent such exemption. 

The Agency’s decision regarding this 

exemption application is based on an 

individualized assessment of the 

applicant’s medical information, 

available medical and scientific data 

concerning narcolepsy, and any relevant 

public comments received. 

IV. Conclusion 

The Agency has determined that the 

available medical and scientific 

literature and research provides 

insufficient data to enable the Agency to 

conclude that granting this exemption 

would achieve a level of safety 

equivalent to, or greater than, the level 

of safety maintained without the 

exemption. Therefore, the following 

applicant has been denied an exemption 

from the physical qualification 

standards in § 391.41(b)(8): 

Sheila Bennett (TN) 

The applicant has, prior to this notice, 

received a letter of final disposition 

regarding their exemption request. The 

decision letter fully outlined the basis 

for the denial and constitute final action 

by the Agency. The name of the 

individual published in this notice 

summarizes the Agency’s recent denials 

as required under 49 U.S.C. 31315(b)(4). 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–09016 Filed 4–27–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–1998–4334; 

FMCSA–1999–6156; FMCSA–1999–6480; 

FMCSA–2001–10578; FMCSA–2002–11714; 

FMCSA–2002–12844; FMCSA–2003–15892; 

FMCSA–2003–16564; FMCSA–2004–17984; 

FMCSA–2004–18885; FMCSA–2005–21254; 

FMCSA–2005–21711; FMCSA–2005–22194; 

FMCSA–2005–22727; FMCSA–2005–23238; 

FMCSA–2006–24015; FMCSA–2006–24783; 

FMCSA–2007–0017; FMCSA–2007–27897; 

FMCSA–2008–0021; FMCSA–2008–0174; 

FMCSA–2008–0231; FMCSA–2008–0266; 

FMCSA–2008–0292; FMCSA–2009–0011; 

FMCSA–2009–0154; FMCSA–2009–0206; 

FMCSA–2009–0291; FMCSA–2009–0303; 

FMCSA–2010–0372; FMCSA–2010–0385; 

FMCSA–2011–0102; FMCSA–2011–0124; 

FMCSA–2011–0140; FMCSA–2011–0275; 

FMCSA–2011–0299; FMCSA–2011–0324; 

FMCSA–2011–0325; FMCSA–2011–0365; 

FMCSA–2011–0366; FMCSA–2011–0378; 

FMCSA–2011–0379; FMCSA–2011–0380; 

FMCSA–2011–26690; FMCSA–2012–0279; 

FMCSA–2012–0338; FMCSA–2013–0022; 

FMCSA–2013–0026; FMCSA–2013–0027; 

FMCSA–2013–0028; FMCSA–2013–0165; 

FMCSA–2013–0166; FMCSA–2013–0167; 

FMCSA–2013–0168; FMCSA–2013–0169; 

FMCSA–2013–0170; FMCSA–2013–0174; 

FMCSA–2014–0002; FMCSA–2014–0003; 

FMCSA–2014–0004; FMCSA–2014–0010; 

FMCSA–2014–0296; FMCSA–2014–0298; 

FMCSA–2015–0048; FMCSA–2015–0049; 

FMCSA–2015–0052; FMCSA–2015–0053; 

FMCSA–2015–0055; FMCSA–2015–0056; 

FMCSA–2015–0070; FMCSA–2015–0071; 

FMCSA–2015–0072; FMCSA–2015–0344; 

FMCSA–2015–0345; FMCSA–2015–0347; 

FMCSA–2015–0348; FMCSA–2015–0350; 

FMCSA–2015–0351; FMCSA–2016–0024; 

FMCSA–2016–0033; FMCSA–2016–0209; 

FMCSA–2016–0377; FMCSA–2017–0017; 

FMCSA–2017–0019; FMCSA–2017–0024; 

FMCSA–2017–0026; FMCSA–2017–0028; 

FMCSA–2018–0006; FMCSA–2018–0007; 

FMCSA–2018–0008; FMCSA–2018–0010; 

FMCSA–2018–0012; FMCSA–2019–0008; 

FMCSA–2019–0009; FMCSA–2019–0010; 

FMCSA–2019–0013; FMCSA–2019–0015; 

FMCSA–2019–0017; FMCSA–2019–0018; 

FMCSA–2019–0019; FMCSA–2020–0005; 

FMCSA–2020–0006] 

Qualification of Drivers; Exemption 

Applications; Vision 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25339 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for 224 

individuals from the vision requirement 

in the Federal Motor Carrier Safety 

Regulations (FMCSRs) for interstate 

commercial motor vehicle (CMV) 

drivers. The exemptions enable these 

individuals to continue to operate CMVs 

in interstate commerce without meeting 

the vision requirement in one eye. 

DATES: Each group of renewed 

exemptions were applicable on the 

dates stated in the discussions below 

and will expire on the dates provided 

below. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, DOT, 

1200 New Jersey Avenue SE, Room 

W64–224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., ET, Monday through Friday, 

except Federal holidays. If you have 

questions regarding viewing or 

submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Viewing Comments 

To view comments go to 

www.regulations.gov, insert the docket 

number, FMCSA–1998–4334, FMCSA– 

1999–6156, FMCSA–1999–6480, 

FMCSA–2001–10578, FMCSA–2002– 

11714, FMCSA–2002–12844, FMCSA– 

2003–15892, FMCSA–2003–16564, 

FMCSA–2004–17984, FMCSA–2004– 

18885, FMCSA–2005–21254, FMCSA– 

2005–21711, FMCSA–2005–22194, 

FMCSA–2005–22727, FMCSA–2005– 

23238, FMCSA–2006–24015, FMCSA– 

2006–24783, FMCSA–2007–0017, 

FMCSA–2007–27897, FMCSA–2008– 

0021, FMCSA–2008–0174, FMCSA– 

2008–0231, FMCSA–2008–0266, 

FMCSA–2008–0292, FMCSA–2009– 

0011, FMCSA–2009–0154, FMCSA– 

2009–0206, FMCSA–2009–0291, 

FMCSA–2009–0303, FMCSA–2010– 

0372, FMCSA–2010–0385, FMCSA– 

2011–0102, FMCSA–2011–0124, 

FMCSA–2011–0140, FMCSA–2011– 

0275, FMCSA–2011–0299, FMCSA– 

2011–0324, FMCSA–2011–0325, 

FMCSA–2011–0365, FMCSA–2011– 

0366, FMCSA–2011–0378, FMCSA– 

2011–0379, FMCSA–2011–0380, 

FMCSA–2011–26690, FMCSA–2012– 

0279, FMCSA–2012–0338, FMCSA– 

2013–0022, FMCSA–2013–0026, 

FMCSA–2013–0027, FMCSA–2013– 

0028, FMCSA–2013–0165, FMCSA– 

2013–0166, FMCSA–2013–0167, 

FMCSA–2013–0168, FMCSA–2013– 

0169, FMCSA–2013–0170, FMCSA– 

2013–0174, FMCSA–2014–0002, 

FMCSA–2014–0003, FMCSA–2014– 

0004, FMCSA–2014–0010, FMCSA– 

2014–0296, FMCSA–2014–0298, 

FMCSA–2015–0048, FMCSA–2015– 

0049, FMCSA–2015–0052, FMCSA– 

2015–0053, FMCSA–2015–0055, 

FMCSA–2015–0056, FMCSA–2015– 

0070, FMCSA–2015–0071, FMCSA– 

2015–0072, FMCSA–2015–0344, 

FMCSA–2015–0345, FMCSA–2015– 

0347, FMCSA–2015–0348, FMCSA– 

2015–0350, FMCSA–2015–0351, 

FMCSA–2016–0024, FMCSA–2016– 

0033, FMCSA–2016–0209, FMCSA– 

2016–0377, FMCSA–2017–0017, 

FMCSA–2017–0019, FMCSA–2017– 

0024, FMCSA–2017–0026, FMCSA– 

2017–0028, FMCSA–2018–0006, 

FMCSA–2018–0007, FMCSA–2018– 

0008, FMCSA–2018–0010, FMCSA– 

2018–0012, FMCSA–2019–0008, 

FMCSA–2019–0009, FMCSA–2019– 

0010, FMCSA–2019–0013, FMCSA– 

2019–0015, FMCSA–2019–0017, 

FMCSA–2019–0018, FMCSA–2019– 

0019, FMCSA–2020–0005, or FMCSA– 

2020–0006 in the keyword box, and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, and click ‘‘Browse 

Comments.’’ If you do not have access 

to the internet, you may view the docket 

online by visiting Dockets Operations in 

Room W12–140 on the ground floor of 

the DOT West Building, 1200 New 

Jersey Avenue SE, Washington, DC 

20590–0001, between 9 a.m. and 5 p.m., 

ET, Monday through Friday, except 

Federal holidays. To be sure someone is 

there to help you, please call (202) 366– 

9317 or (202) 366–9826 before visiting 

Dockets Operations. 

B. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

request. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.dot.gov/privacy. 

II. Background 

On March 1, 2022, FMCSA published 

a notice announcing its decision to 

renew exemptions for 224 individuals 

from the vision requirement in 49 CFR 

391.41(b)(10) to operate a CMV in 

interstate commerce and requested 

comments from the public (87 FR 

11496). The public comment period 

ended on March 31, 2022, and no 

comments were received to the docket 

in this proceeding. 

FMCSA has evaluated the eligibility 

of these applicants and determined that 

renewing these exemptions would 

achieve a level of safety equivalent to, 

or greater than, the level that would be 

achieved by complying with the current 

regulation § 391.41(b)(10). 

The physical qualification standard 

for drivers regarding vision found in 

§ 391.41(b)(10) states that a person is 

physically qualified to drive a CMV if 

that person has distant visual acuity of 

at least 20/40 (Snellen) in each eye 

without corrective lenses or visual 

acuity separately corrected to 20/40 

(Snellen) or better with corrective 

lenses, distant binocular acuity of a least 

20/40 (Snellen) in both eyes with or 

without corrective lenses, field of vision 

of at least 70° in the horizontal meridian 

in each eye, and the ability to recognize 

the colors of traffic signals and devices 

showing red, green, and amber. 

III. Discussion of Comments 

FMCSA received no comments to the 

docket in this proceeding. 

IV. Conclusion 

Based on its evaluation of the 224 

renewal exemption applications and 

comments received, FMCSA confirms 

its decision to exempt the following 

drivers from the vision requirement in 

§ 391.41(b)(10). 

As of March 2, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following 127 individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the vision 

requirement in the FMCSRs for 

interstate CMV drivers (63 FR 66227; 64 

FR 16520; 64 FR 54948; 65 FR 159; 66 

FR 53826; 66 FR 66966; 66 FR 66969; 

68 FR 52811; 68 FR 61860; 68 FR 69432; 

68 FR 69434; 69 FR 33997; 69 FR 53493; 

69 FR 61292; 69 FR 62741; 70 FR 30999; 

70 FR 46567; 70 FR 48797; 70 FR 48798; 

70 FR 48799; 70 FR 48800; 70 FR 53412; 

70 FR 57353; 70 FR 61165; 70 FR 72689; 

70 FR 74102; 71 FR 644; 71 FR 14566; 

71 FR 30227; 71 FR 32183; 71 FR 41310; 

71 FR 55820; 71 FR 62147; 71 FR 62147; 

72 FR 39879; 72 FR 40359; 72 FR 52419; 

72 FR 58359; 72 FR 62897; 72 FR 67340; 

72 FR 71993; 72 FR 71995; 72 FR 71998; 

73 FR 1395; 73 FR 5259; 73 FR 27014; 

73 FR 38497; 73 FR 46973; 73 FR 48273; 

73 FR 51689; 73 FR 54888; 73 FR 60398; 

73 FR 61922; 73 FR 61925; 73 FR 63047; 

73 FR 65009; 73 FR 74565; 74 FR 19270; 

74 FR 34074; 74 FR 37295; 74 FR 43217; 

74 FR 48343; 74 FR 53581; 74 FR 57551; 

74 FR 60021; 74 FR 60022; 74 FR 64124; 

74 FR 65842; 74 FR 65845; 74 FR 65847; 

75 FR 1451; 75 FR 4623; 75 FR 9482; 75 

FR 44051; 75 FR 50799; 75 FR 64396; 


jspears on DSK121TN23PROD with NOTICES1
25340 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

75 FR 77942; 75 FR 77949; 76 FR 4413; 

76 FR 5425; 76 FR 7894; 76 FR 17483; 

76 FR 20078; 76 FR 25762; 76 FR 29022; 

76 FR 29026; 76 FR 34136; 76 FR 37169; 

76 FR 44082; 76 FR 44653; 76 FR 50318; 

76 FR 55463; 76 FR 64169; 76 FR 64171; 

76 FR 66123; 76 FR 70210; 76 FR 70212; 

76 FR 73769; 76 FR 75942; 76 FR 75943; 

76 FR 78728; 76 FR 78729; 76 FR 79760; 

77 FR 539; 77 FR 543; 77 FR 545; 77 FR 

3547; 77 FR 10604; 77 FR 10608; 77 FR 

46153; 77 FR 60008; 77 FR 64582; 77 FR 

68202; 77 FR 71671; 77 FR 74731; 78 FR 

10250; 78 FR 12811; 78 FR 12815; 78 FR 

16762; 78 FR 22598; 78 FR 22602; 78 FR 

24300; 78 FR 24798; 78 FR 27281; 78 FR 

30954; 78 FR 37274; 78 FR 41188; 78 FR 

46407; 78 FR 47818; 78 FR 51268; 78 FR 

62935; 78 FR 63302; 78 FR 63307; 78 FR 

64271; 78 FR 64274; 78 FR 65032; 78 FR 

66099; 78 FR 67452; 78 FR 67454; 78 FR 

67462; 78 FR 68137; 78 FR 76395; 78 FR 

76704; 78 FR 76705; 78 FR 76707; 78 FR 

77778; 78 FR 77780; 78 FR 77782; 78 FR 

78475; 78 FR 78477; 79 FR 2247; 79 FR 

2748; 79 FR 3919; 79 FR 4531; 79 FR 

4803; 79 FR 6993; 79 FR 10619; 79 FR 

18392; 79 FR 29498; 79 FR 46153; 79 FR 

51643; 79 FR 53708; 79 FR 56104; 79 FR 

58856; 79 FR 64001; 79 FR 65759; 79 FR 

65760; 79 FR 69985; 79 FR 72754; 80 FR 

7679; 80 FR 8927; 80 FR 14220; 80 FR 

16500; 80 FR 18696; 80 FR 26139; 80 FR 

26320; 80 FR 31635; 80 FR 31636; 80 FR 

33007; 80 FR 35699; 80 FR 36395; 80 FR 

36398; 80 FR 37718; 80 FR 40122; 80 FR 

41547; 80 FR 44188; 80 FR 48404; 80 FR 

48409; 80 FR 48413; 80 FR 50917; 80 FR 

59225; 80 FR 59230; 80 FR 62161; 80 FR 

62163; 80 FR 63869; 80 FR 67472; 80 FR 

67476; 80 FR 67481; 80 FR 70060; 80 FR 

76345; 80 FR 79414; 80 FR 80443; 81 FR 

1284; 81 FR 11642; 81 FR 15401; 81 FR 

15404; 81 FR 16265; 81 FR 20433; 81 FR 

44680; 81 FR 59266; 81 FR 60117; 81 FR 

70251; 81 FR 74494; 81 FR 90050; 81 FR 

91239; 81 FR 96165; 81 FR 96178; 81 FR 

96180; 82 FR 13045; 82 FR 15277; 82 FR 

18949; 82 FR 18956; 82 FR 20962; 82 FR 

22379; 82 FR 23712; 82 FR 32919; 82 FR 

33542; 82 FR 35043; 82 FR 37499; 82 FR 

47295; 82 FR 47312; 82 FR 47313; 82 FR 

58262; 83 FR 2306; 83 FR 2311; 83 FR 

3861; 83 FR 4537; 83 FR 6919; 83 FR 

6922; 83 FR 6925; 83 FR 15232; 83 FR 

18648; 83 FR 53724; 84 FR 2314; 84 FR 

2326; 84 FR 12665; 84 FR 16320; 84 FR 

16333; 84 FR 21397; 84 FR 21401; 84 FR 

23629; 84 FR 27688; 84 FR 28619; 84 FR 

46088; 84 FR 47038; 84 FR 47047; 84 FR 

47056; 84 FR 47057; 84 FR 52160; 84 FR 

52166; 84 FR 58437; 84 FR 58441; 84 FR 

58448; 84 FR 66442; 84 FR 66444; 84 FR 

68288; 84 FR 69814; 84 FR 72114; 84 FR 

72120; 85 FR 4764; 85 FR 4769; 85 FR 

6993; 85 FR 8334; 85 FR 9932): 

Juan D. Adame (TX) 

Gary R. Andersen (NE) 

Garry A. Baker (OH) 

Joel D. Barchard (MA) 

Stephen W. Barrows (OR) 

Theodore N. Belcher (VA) 

Steven A. Blinco (MT) 

Rickie L. Boone (NC) 

Jerry A. Bordelon (LA) 

David B. Bowman (PA) 

Walter A. Breeze (OH) 

Eugene R. Briggs (MI) 

John M. Brown (KY) 

Raymond K. Brubaker (WA) 

Larry W. Buchanan (NM) 

Cris D. Bush (TN) 

James E. Byrnes (MO) 

Joseph A. Cardazone (NJ) 

Henry L. Chastain (GA) 

Lesco R. Chubb (GA) 

Joseph A. Clark (WI) 

Stewart K. Clayton (TX) 

Donald O. Clopton (AL) 

Joseph Coelho (RI) 

James J. Coffield (NM) 

Marion J. Coleman, Jr. (KY) 

Adan Cortes-Juarez (WA) 

Zackary C. Crichton (WY) 

Kenneth D. Daniels (PA) 

Deurice K. Dean (MD) 

John A. DeVos (VT) 

Bradley R. Dishman (KY) 

James J. Doan (PA) 

Bruce J. Dowd (CT) 

Micheal H. Eheler (WI) 

David E. Evans (NC) 

Mark A. Farnsley (IN) 

James P. Fitzgerald (MA) 

Clarence N. Florey, Jr. (PA) 

Ronald W. Garner (WA) 

Darryl W. Hardy (AL) 

Dewayne E. Harms (IL) 

John M. Harvey (TX) 

Steven M. Hoover (IL) 

Jesus J. Huerta (NV) 

Amos W. Hulsey (AL) 

Darryl H. Johnson (WV) 

Freddie H. Johnson (ID) 

David B. Jones (FL) 

Rufus L. Jones (NJ) 

Alfred Keehn (AZ) 

Karen L. Kelly (DE) 

Theodore J. Kenyon (VT) 

Dobbin L. Kirkbride (OH) 

Robert W. Kleve (IA) 

Thomas Korycki (NJ) 

Larry G. Kreke (IL) 

Rocky J. Lachney (LA) 

Adam S. Larson (CO) 

Chase L. Larson (WA) 

Richard L. Loeffelholz (WI) 

Leonardo Lopez (NE) 

Anthony Luciano (CT) 

Robert J. MacInnis (MA) 

Rodolfo Martinez (TX) 

Christopher V. May (GA) 

Robert E. Mayers (MN) 

Dean A. Maystead (MI) 

Colin D. McGregor (WI) 

Kevin D. Mendoza (WA) 

Gregory G. Miller (OH) 

James G. Mitchell (AL) 

Rashawn L. Morris (VA) 

Kenneth R. Murphy (WA) 

Brian T. Nelson (MN) 

James P. O’Berry (GA) 

Steven D. O’Donnell (NJ) 

Charles D. Oestreich (MN) 

Carlos A. Osollo (NM) 

William K. Otwell (LA) 

Anthony D. Ovitt (VT) 

Gerardo A. Padron (FL) 

Daniel F. Perez (CA) 

Joe M. Perez (TX) 

Nathan Pettis (FL) 

Johnny L. Powell (MD) 

Kerry R. Powers (IN) 

Kevin L. Quastad (IA) 

Jason R. Raml (SD) 

Branden J. Ramos (CA) 

David J. Reed (TX) 

Robert D. Reeder (MI) 

Martin S. Reese (CA) 

Christopher M. Rivera (NM) 

Charles J. Rowsey (NC) 

Carl W. Russell (OK) 

Manuel H. Sanchez (TX) 

Robert E. Sanders (PA) 

Phillip D. Satterfield (GA) 

Justin E. Schwada (MO) 

Jarrod R. Seirer (KS) 

Jeffery T. Skaggs (IA) 

James J. Slemmer (PA) 

John R. Snyder (WA) 

Efren J. Soliz (NM) 

Juan E. Sotero (FL) 

Mark R. Stevens (IA) 

Dale L. Stewart (MI) 

Kenneth C. Stump (FL) 

Sukru Tamirci (NY) 

Robert Thomas (PA) 

James L. Tinsley, Jr. (VA) 

George E. Todd (WV) 

Rene R. Trachsel (OR) 

Stanley W. Tyler, Jr. (NC) 

Victor H. Vera (TX) 

Daniel R. Viscaya (NC) 

John H. Voigts (AZ) 

Gary D. Vollertsen (CO) 

David L. Von Hagen (IA) 

James H. Wallace, Sr. (FL) 

Stephen H. Ward (MO) 

James A. Welch (NH) 

Richard A. Westfall (OH) 

Lorenzo A. Williams (DE) 

Reginald J. Wuethrich (IL) 

Chadwick L. Wyatt (NC) 

The drivers were included in docket 

numbers FMCSA–1998–4334; FMCSA– 

1999–6156; FMCSA–2001–10578; 

FMCSA–2003–15892; FMCSA–2004– 

17984; FMCSA–2004–18885; FMCSA– 

2005–21254; FMCSA–2005–21711; 

FMCSA–2005–22194; FMCSA–2006– 

24015; FMCSA–2006–24783; FMCSA– 

2007–0017; FMCSA–2007–27897; 

FMCSA–2008–0174; FMCSA–2008– 

0231; FMCSA–2008–0266; FMCSA– 

2008–0292; FMCSA–2009–0154; 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25341 

FMCSA–2009–0206; FMCSA–2009– 

0291; FMCSA–2009–0303; FMCSA– 

2010–0372; FMCSA–2010–0385; 

FMCSA–2011–0102; FMCSA–2011– 

0124; FMCSA–2011–0140; FMCSA– 

2011–0299; FMCSA–2011–0325; 

FMCSA–2011–26690; FMCSA–2012– 

0279; FMCSA–2012–0338; FMCSA– 

2013–0022; FMCSA–2013–0026; 

FMCSA–2013–0027; FMCSA–2013– 

0028; FMCSA–2013–0165; FMCSA– 

2013–0166; FMCSA–2013–0167; 

FMCSA–2013–0168; FMCSA–2013– 

0169; FMCSA–2013–0170; FMCSA– 

2014–0004; FMCSA–2014–0010; 

FMCSA–2014–0296; FMCSA–2014– 

0298; FMCSA–2015–0048; FMCSA– 

2015–0049; FMCSA–2015–0052; 

FMCSA–2015–0053; FMCSA–2015– 

0055; FMCSA–2015–0056; FMCSA– 

2015–0070; FMCSA–2015–0071; 

FMCSA–2015–0072; FMCSA–2015– 

0344; FMCSA–2015–0345; FMCSA– 

2016–0033; FMCSA–2016–0209; 

FMCSA–2016–0377; FMCSA–2017– 

0017; FMCSA–2017–0019; FMCSA– 

2017–0024; FMCSA–2017–0026; 

FMCSA–2019–0008; FMCSA–2019– 

0009; FMCSA–2019–0010; FMCSA– 

2019–0013; FMCSA–2019–0015; 

FMCSA–2019–0017; FMCSA–2019– 

0018; FMCSA–2019–0019. Their 

exemptions were applicable as of March 

2, 2022 and will expire on March 2, 

2024. 

As of March 7, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following individual has 

satisfied the renewal conditions for 

obtaining an exemption from the vision 

requirement in the FMCSRs for 

interstate CMV drivers (77 FR 3552; 77 

FR 13691; 79 FR 12565; 81 FR 20433; 

83 FR 6919; 85 FR 6993): 

Samuel V. Holder (IL) 

The driver was included in docket 

number FMCSA–2011–0365. The 

exemption was applicable as of March 

7, 2022 and will expire on March 7, 

2024. 

As of March 10, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following six individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the vision 

requirement in the FMCSRs for 

interstate CMV drivers (81 FR 6573; 81 

FR 28136; 83 FR 6919; 85 FR 6993; 85 

FR 6997; 85 FR 19220): 

Thomas M. Bowman (OH) 

Robert W. Fawcett (PA) 

Lester Johnson (GA) 

Dennis C. Rokes (IA) 

Brian Wayne Roughton (MO) 

Juan Santay-Ajanel (DE) 

The drivers were included in docket 

numbers FMCSA–2015–0348; and 

FMCSA–2020–0005. Their exemptions 

were applicable as of March 10, 2022 

and will expire on March 10, 2024. 

As of March 13, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following three 

individuals have satisfied the renewal 

conditions for obtaining an exemption 

from the vision requirement in the 

FMCSRs for interstate CMV drivers (79 

FR 1908; 79 FR 14333; 81 FR 20433; 83 

FR 6919; 85 FR 6993): 

Justin W. Demarchi (OH); David G. 

Henry (TX); and Jason C. Sadler (KY) 

The drivers were included in docket 

number FMCSA–2013–0174. Their 

exemptions were applicable as of March 

13, 2022 and will expire on March 13, 

2024. 

As of March 17, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following six individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the vision 

requirement in the FMCSRs for 

interstate CMV drivers (83 FR 6681; 83 

FR 6694; 83 FR 24151; 83 FR 24571; 85 

FR 6993): 

Kenneth W. Blake (KS) 

James M. Ferry (OH) 

Jacob A. Hehr (IL) 

Marvin Ronald Knecht (ND) 

Martin Munoz (TX) 

Robert Lee Redding (NC) 

The drivers were included in docket 

numbers FMCSA–2017–0028; and 

FMCSA–2018–0006. Their exemptions 

were applicable as of March 17, 2022 

and will expire on March 17, 2024. 

As of March 22, 2022, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following 81 individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the vision 

requirement in the FMCSRs for 

interstate CMV drivers (64 FR 68195; 65 

FR 20251; 67 FR 15662; 67 FR 17102; 

67 FR 37907; 67 FR 68719; 68 FR 2629; 

68 FR 74699; 69 FR 10503; 69 FR 17267; 

69 FR 26206; 69 FR 71100; 70 FR 71884; 

71 FR 4632; 71 FR 5105; 71 FR 6829; 71 

FR 16410; 71 FR 19600; 71 FR 26602; 

72 FR 1053; 72 FR 39879; 72 FR 52422; 

73 FR 5259; 73 FR 11989; 73 FR 15254; 

73 FR 15567; 73 FR 27014; 73 FR 27015; 

73 FR 27017; 73 FR 76440; 74 FR 49069; 

74 FR 65842; 75 FR 1451; 75 FR 9480; 

75 FR 9482; 75 FR 13653; 75 FR 19674; 

75 FR 20881; 75 FR 22176; 75 FR 27621; 

75 FR 27622; 76 FR 64164; 76 FR 75942; 

77 FR 545; 77 FR 3547; 77 FR 5874; 77 

FR 7657; 77 FR 10604; 77 FR 15184; 77 

FR 17107; 77 FR 17108; 77 FR 17115; 

77 FR 17117; 77 FR 19749; 77 FR 22059; 

77 FR 22838; 77 FR 23797; 77 FR 26816; 

77 FR 27849; 77 FR 27850; 78 FR 64271; 

78 FR 64274; 78 FR 67452; 78 FR 77778; 

78 FR 78475; 79 FR 1908; 79 FR 2247; 

79 FR 2748; 79 FR 10606; 79 FR 10607; 

79 FR 10610; 79 FR 10619; 79 FR 13085; 

79 FR 14333; 79 FR 14571; 79 FR 15794; 

79 FR 17641; 79 FR 17642; 79 FR 17643; 

79 FR 18390; 79 FR 18391; 79 FR 18392; 

79 FR 21996; 79 FR 22003; 79 FR 23797; 

79 FR 28588; 79 FR 29498; 80 FR 67476; 

80 FR 67481; 80 FR 70060; 80 FR 76345; 

80 FR 79414; 80 FR 80443; 81 FR 1474; 

81 FR 14190; 81 FR 15404; 81 FR 16265; 

81 FR 17237; 81 FR 20433; 81 FR 20435; 

81 FR 21655; 81 FR 28138; 81 FR 39100; 

81 FR 44680; 81 FR 48493; 81 FR 52516; 

81 FR 60117; 81 FR 66718; 81 FR 91239; 

83 FR 2311; 83 FR 6681; 83 FR 6919; 83 

FR 6922; 83 FR 6925; 83 FR 15195; 83 

FR 15214; 83 FR 15216; 83 FR 18644; 

83 FR 18648; 83 FR 24146; 83 FR 24151; 

83 FR 28320; 83 FR 28323; 83 FR 28328; 

83 FR 28342; 83 FR 45749; 85 FR 6993; 

85 FR 12959; 85 FR 19224; 85 FR 21919; 

85 FR 33784): 

Thomas R. Abbott (TN) 

Zachary A. Abbotts (CT) 

Ahmed Abukhatwa (MI) 

Ronald C. Ashley (GA) 

James E. Baker (OH) 

Terry M. Baldwin (PA) 

Aaron D. Barnett (IA) 

Dmitriy D. Bayda (WA) 

Thomas Benavidez, Jr. (ID) 

Donald J. Bierwirth, Jr. (CT) 

Lee R. Boykin (TX) 

Robert L. Brauns (IA) 

Joe W. Brewer (SC) 

James A. Champion (WA) 

Loren D. Chapman (MN) 

Dana L. Colberg (OR) 

Walter F. Crean, III (CT) 

William T. Cummins (KY) 

James T. Curtis (NM) 

Jim L. Davis (NM) 

Clifford W. Doran, Jr. (NC) 

Jason P. Dostal (IN) 

John C. Duncan (FL) 

James W. Ellis, 4th (NJ) 

Spencer L. Goard (KY) 

Danny R. Gray (OK) 

Glenn C. Grimm (NJ) 

Hugo N. Gutierrez (IN) 

Keith J. Haaf (VA) 

Ethan A. Hale (KY) 

Thomas R. Hedden (IL) 

Trevor M. Hilton (IL) 

Neil W. Jennings (MO) 

Robert E. Johnston, Jr. (WA) 

William J. Kanaris (NY) 

James D. Kessler (SD) 

Matthew J. Konecki (MT) 

Richard R. Krafczynski (PA) 

Jeffrey T. Landry (NC) 

Robert G. Lanning (VA) 

Gary D. Larson (NE) 

Paul K. Leger (NH) 

Earl E. Martin (VA) 

Herman Martinez (NM) 

Martin L. Mayes (GA) 

Trent C. McCain (KS) 

David M. McCarty (OR) 


jspears on DSK121TN23PROD with NOTICES1
25342 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

1Section 205 of the Rail Safety Improvement Act 

of 2008 (RSIA), Public Law 110–432, Division A 

(October 16, 2008). 

Dale A. McCoy (ME) 

Cole W. McLaughlin (SD) 

Rodney J. McMorran (IA) 

Daniel A. McNabb, Jr. (KS) 

Daniel I. Miller (PA) 

Darin P. Milton (TN) 

Robert Mollicone (FL) 

Russell L. Moyers, Sr. (WV) 

Robert L. Murray (IL) 

Millard F. Neace II (WV) 

Michael Nichols (GA) 

Harold D. Pressley (TX) 

Erik M. Rice (TX) 

Douglas L. Riddell (CA) 

John M. Riley (AL) 

Gilbert M. Rosas (AZ) 

Donald P. Ruckinger (PA) 

Michael B. Sauseda (IL) 

Tatum R. Schmidt (IA) 

Harry J. Scholl (PA) 

Kim A. Shaffer (PA) 

Jeffery A. Sheets (AR) 

Colby T. Smith (UT) 

Aaron S. Taylor (WI) 

Michael A. Terry (IN) 

Glenn R. Theis (MN) 

Hany A. Wagieh (NJ) 

Eddie Walker (NC) 

Norman J. Watson (NC) 

Charles T. Whitehead (NC) 

Ronald D. Wilson (KY) 

Elmer F. Winters (NC) 

Trent Wipf (SD) 

Kevin Young (NJ) 

The drivers were included in docket 

numbers FMCSA–1999–6480; FMCSA– 

2002–11714; FMCSA–2002–12844; 

FMCSA–2003–16564; FMCSA–2005– 

22727; FMCSA–2005–23238; FMCSA– 

2007–27897; FMCSA–2008–0021; 

FMCSA–2009–0011; FMCSA–2009– 

0291; FMCSA–2011–0275; FMCSA– 

2011–0324; FMCSA–2011–0366; 

FMCSA–2011–0378; FMCSA–2011– 

0379; FMCSA–2011–0380; FMCSA– 

2013–0167; FMCSA–2013–0169; 

FMCSA–2013–0174; FMCSA–2014– 

0002; FMCSA–2014–0003; FMCSA– 

2014–0004; FMCSA–2015–0070; 

FMCSA–2015–0072; FMCSA–2015– 

0344; FMCSA–2015–0345; FMCSA– 

2015–0347; FMCSA–2015–0350; 

FMCSA–2015–0351; FMCSA–2016– 

0024; FMCSA–2017–0026; FMCSA– 

2017–0028; FMCSA–2018–0007; 

FMCSA–2018–0008; FMCSA–2018– 

0010; FMCSA–2018–0012; and FMCSA– 

2020–0006. Their exemptions were 

applicable as of March 22, 2022 and will 

expire on March 22, 2024. 

In accordance with 49 U.S.C. 

31315(b), each exemption will be valid 

for 2 years from the effective date unless 

revoked earlier by FMCSA. The 

exemption will be revoked if the 

following occurs: (1) The person fails to 

comply with the terms and conditions 

of the exemption; (2) the exemption has 

resulted in a lower level of safety than 

was maintained prior to being granted; 

or (3) continuation of the exemption 

would not be consistent with the goals 

and objectives of 49 U.S.C. 31136(e) and 

31315(b). 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–09018 Filed 4–27–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Railroad Administration 

[Docket No. FRA–2022–0002–N–6] 

Proposed Agency Information 

Collection Activities; Comment 

Request 

AGENCY: Federal Railroad 

Administration (FRA), Department of 

Transportation (DOT). 

ACTION: Notice of information collection; 

request for comment. 

SUMMARY: Under the Paperwork 

Reduction Act of 1995 (PRA) and its 

implementing regulations, FRA seeks 

approval of the Information Collection 

Request (ICR) abstracted below. Before 

submitting this ICR to the Office of 

Management and Budget (OMB) for 

approval, FRA is soliciting public 

comment on specific aspects of the 

activities identified in the ICR. 

DATES: Interested persons are invited to 

submit comments on or before June 27, 

2022. 

ADDRESSES: Written comments and 

recommendations for the proposed ICR 

should be submitted on regulations.gov 

to the docket, Docket No. FRA–2022– 

0002. All comments received will be 

posted without change to the docket, 

including any personal information 

provided. Please refer to the assigned 

OMB control number in any 

correspondence submitted. FRA will 

summarize comments received in 

response to this notice in a subsequent 

notice and include them in its 

information collection submission to 

OMB for approval. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Hodan Wells, Information Collection 

Clearance Officer, at email: 

hodan.wells@dot.gov or telephone: (202) 

493–0440. 

SUPPLEMENTARY INFORMATION: The PRA, 

44 U.S.C. 3501–3520, and its 

implementing regulations, 5 CFR part 

1320, require Federal agencies to 

provide 60-days’ notice to the public to 

allow comment on information 

collection activities before seeking OMB 

approval of the activities. See 44 U.S.C. 

3506, 3507; 5 CFR 1320.8 through 

1320.12. Specifically, FRA invites 

interested parties to comment on the 

following ICR regarding: (1) Whether the 

information collection activities are 

necessary for FRA to properly execute 

its functions, including whether the 

activities will have practical utility; (2) 

the accuracy of FRA’s estimates of the 

burden of the information collection 

activities, including the validity of the 

methodology and assumptions used to 

determine the estimates; (3) ways for 

FRA to enhance the quality, utility, and 

clarity of the information being 

collected; and (4) ways for FRA to 

minimize the burden of information 

collection activities on the public, 

including the use of automated 

collection techniques or other forms of 

information technology. See 44 U.S.C. 

3506(c)(2)(A); 5 CFR 1320.8(d)(1). 

FRA believes that soliciting public 

comment may reduce the administrative 

and paperwork burdens associated with 

the collection of information that 

Federal regulations mandate. In 

summary, FRA reasons that comments 

received will advance three objectives: 

(1) Reduce reporting burdens; (2) 

organize information collection 

requirements in a ‘‘user-friendly’’ format 

to improve the use of such information; 

and (3) accurately assess the resources 

expended to retrieve and produce 

information requested. See 44 U.S.C. 

3501. 

The summary below describes the ICR 

that FRA will submit for OMB clearance 

as the PRA requires: 

Title: System for Telephonic 

Notification of Unsafe Conditions at 

Highway-Rail and Pathway Grade 

Crossings. 

OMB Control Number: 2130–0591. 

Abstract: The collection of 

information set forth under 49 CFR part 

234 is used by FRA to ensure that the 

Congressional mandate 1 to require 

railroad carriers to establish and 

maintain a toll-free telephone service to 

report unsafe conditions at highway-rail 

and pathway grade crossings is carried 

out. This information is used by 

railroads to investigate and respond to 

unsafe conditions and thereby reduce 

the risk of accidents/incidents and 

corresponding casualties and property 

damage at such crossings. Additionally, 

law enforcement authorities use the 

information to direct vehicular traffic or 

carry out other activities to maintain 

safety at the highway-rail grade crossing 

or pathway grade crossing. 


jspears on DSK121TN23PROD with NOTICES1